No savings at 50? I’d buy these 2 FTSE 100 dividend shares and retire on a passive income

I reckon these two FTSE 100 shares have significant potential to boost your wealth in retirement.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

What should you do if you arrive at the age of 50 and find yourself without any meaningful savings? I reckon you should do exactly as you could have done at 20, 30 and 40 – invest in shares with good-quality underlying businesses.

I’d look for companies with a strong record of trading and finances, and invest in the shares to collect the shareholder dividends. Leading up to retirement I’d reinvest the income from dividends back into shares to compound the investment. Then, in retirement, I’d collect the dividends to live on passive income.

Pharmaceuticals

The pharmaceutical sector, in general, is known for its defensive characteristics and companies operating in the industry often generate steady cash flow, which supports shareholder dividends.

The FTSE 100’s AstraZeneca (LSE: AZN), with its share price near 7,624p, has a forward-looking dividend yield for 2020 of around 2.8%. And the directors have held the dividend flat for several years, despite the well-publicised problems in the sector relating to patent expiry issues.

From 2016 through to 2018, the company’s profits suffered, but since 2019 they’ve been bouncing back. And City analysts following the firm expect earnings to cover the dividend payment more than 1.5 times in 2020. That situation will mark a nice recovery for the firm, and it’s been driven by a vibrant research and development pipeline that has been producing new big-earning products.

Once again, the future looks bright for AstraZeneca, in my opinion, and I’d be keen to add some of the shares to my long-term retirement portfolio.

Fast-moving consumer goods

Companies don’t have to sell medicines to reap repetitive business from consumers. Reckitt Benckiser (LSE: RB) is another in London’s lead FTSE 100 index that tends to enjoy strong, dependable cash flow because of customers that return often for more.

The firm sells products in the area of hygiene with brands names such as Dettol, Harpic, Cillit Bang, Vanish and Finish. And it also has one foot in the healthcare market with brands such as Gaviscon and Nurofen.

Although earnings have been a little weak lately, the cash flow has been standing up well by remaining broadly flat. And the dividends keep on coming for shareholders. I think the company could make a good long-term hold for investors and may return to growth in the future. And chief executive Laxman Narasimhan said in an update last October that he thinks the company has “significant potential” because of its “outstanding” set of brands in structural growth categories. 

With the shares at 6,250p, the forward-looking dividend yield is running near 2.7% and City analysts following the firm expect earnings to cover the shareholder payment almost twice. Meanwhile, the share price is down from the peak it achieved in the summer of 2017, and I think now could be a good time to add the stock to my long-term portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »

View of Tower Bridge in Autumn
Investing Articles

The FTSE 100 is closing in on 8,000 points! Here’s what I’m buying before it’s too late!

As the FTSE 100 keeps gaining momentum, this Fool is on the lookout for bargains. Here's one stock he'd willingly…

Read more »

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »